| Synergic Health, Llc | |
|
1151 W Main St, Richmond, VT 05477-4472 | |
| (802) 434-5437 | |
| (802) 329-2163 |
| Full Name | Synergic Health, Llc |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 1151 W Main St, Richmond, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770958662 | NPI | - | NPPES |
| 1015666 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 006.0001157 (Vermont) | Primary |
| Provider Name | Erin Sepic |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1538255419 PECOS PAC ID: 0446527295 Enrollment ID: I20170531000580 |
News Archive
The so-called RANK protein and the molecule that binds to it, the RANK ligand or RANKL, form a focus of the work of Josef Penninger, director of the Institute of Molecular Biotechnology (IMBA) in Vienna. In 1999 his group deleted the RANKL gene from mice and showed that the RANK/RANKL system was the "master regulator" governing bone loss (Kong et al. 1999 Nature 402, 304-309).
Many children are being put at risk by parents over-use of widely available over the counter (OTC) medicines for fever, coughs and colds, says a study from Australia to be presented to the annual conference of the International Pharmaceutical Federation (FIP) today (Monday 30 August).
Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad' cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU's mutual recognition procedure.
Media outlets report on this and other health law implementation developments, including news about health exchanges and the measure's pre-existing condition insurance plan.
Many middle-aged and older adults with diabetes are sexually active according to a study of nearly 2,000 people aged 57 to 85 presented in the September 2010 issue of the journal Diabetes Care. Almost 70 percent of partnered men with diabetes and 62 percent of partnered women with diabetes engaged in sexual activity two or three times a month, comparable to those without diabetes, the study showed.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Synergic Health, Llc 1151 W Main St, Richmond, VT 05477-4472 Ph: (802) 434-5437 | Synergic Health, Llc 1151 W Main St, Richmond, VT 05477-4472 Ph: (802) 434-5437 |
News Archive
The so-called RANK protein and the molecule that binds to it, the RANK ligand or RANKL, form a focus of the work of Josef Penninger, director of the Institute of Molecular Biotechnology (IMBA) in Vienna. In 1999 his group deleted the RANKL gene from mice and showed that the RANK/RANKL system was the "master regulator" governing bone loss (Kong et al. 1999 Nature 402, 304-309).
Many children are being put at risk by parents over-use of widely available over the counter (OTC) medicines for fever, coughs and colds, says a study from Australia to be presented to the annual conference of the International Pharmaceutical Federation (FIP) today (Monday 30 August).
Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad' cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU's mutual recognition procedure.
Media outlets report on this and other health law implementation developments, including news about health exchanges and the measure's pre-existing condition insurance plan.
Many middle-aged and older adults with diabetes are sexually active according to a study of nearly 2,000 people aged 57 to 85 presented in the September 2010 issue of the journal Diabetes Care. Almost 70 percent of partnered men with diabetes and 62 percent of partnered women with diabetes engaged in sexual activity two or three times a month, comparable to those without diabetes, the study showed.
› Verified 9 days ago
Logan Sangrey, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1070 W Main St Ste 7, Richmond, VT 05477 Phone: 802-399-5578 | |
Erin J Sepic, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1151 W Main St, Richmond, VT 05477 Phone: 802-434-5437 Fax: 802-329-2163 | |
Dr. Jesse Matthew West, Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1151 W Main St, Richmond, VT 05477 Phone: 802-434-5437 | |
Dr. Sarah Ruth Paquette, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1151 W Main St, Richmond, VT 05477 Phone: 802-662-3592 Fax: 802-332-3099 | |
Compass Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1151 W Main St, Richmond, VT 05477 Phone: 802-662-3592 Fax: 802-332-3099 | |
Rooted Movement Rehab Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1070 W Main St Ste 7, Richmond, VT 05477 Phone: 802-399-5578 |